Compile Data Set for Download or QSAR
maximum 50k data
Found 3495 with Last Name = 'oue' and Initial = 'm'
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602107(US11643417, Ex. No. 120)
Affinity DataKi:  0.00600nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602075(US11643417, Ex. No. 90)
Affinity DataKi:  0.00900nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602103(US11643417, Ex. No. 116)
Affinity DataKi:  0.00900nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602160(US11643417, Ex. No. 156)
Affinity DataKi:  0.0100nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602097(US11643417, Ex. No. 111)
Affinity DataKi:  0.0110nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602126(US11643417, Ex. No. 138)
Affinity DataKi:  0.0150nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM601978(US11643417, Ex. No. 11 | US11643417, Ex. No. 12 | ...)
Affinity DataKi:  0.0170nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602169(US11643417, Ex. No. 164)
Affinity DataKi:  0.0190nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602002(US11643417, Ex. No. 34)
Affinity DataKi:  0.0210nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM601981(US11643417, Ex. No. 13)
Affinity DataKi:  0.0210nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602134(US11643417, Ex. No. 146)
Affinity DataKi:  0.0230nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM601982(US11643417, Ex. No. 14 | US11643417, Ex. No. 15 | ...)
Affinity DataKi:  0.0250nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602081(US11643417, Ex. No. 96)
Affinity DataKi:  0.0280nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM601978(US11643417, Ex. No. 11 | US11643417, Ex. No. 12 | ...)
Affinity DataKi:  0.0280nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM601982(US11643417, Ex. No. 14 | US11643417, Ex. No. 15 | ...)
Affinity DataKi:  0.0290nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602114(US11643417, Ex. No. 127 | US11643417, Ex. No. 128)
Affinity DataKi:  0.0310nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602074(US11643417, Ex. No. 89)
Affinity DataKi:  0.0330nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM601982(US11643417, Ex. No. 14 | US11643417, Ex. No. 15 | ...)
Affinity DataKi:  0.0330nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM601977(US11643417, Ex. No. 10 | US11643417, Ex. No. 51)
Affinity DataKi:  0.0330nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602139(US11643417, Ex. No. 149)
Affinity DataKi:  0.0340nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602032(US11643417, Ex. No. 49)
Affinity DataKi:  0.0390nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM601978(US11643417, Ex. No. 11 | US11643417, Ex. No. 12 | ...)
Affinity DataKi:  0.0390nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602044(US11643417, Ex. No. 61)
Affinity DataKi:  0.0390nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM601977(US11643417, Ex. No. 10 | US11643417, Ex. No. 51)
Affinity DataKi:  0.0410nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602092(US11643417, Ex. No. 106)
Affinity DataKi:  0.0410nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetWD repeat-containing protein 5(Homo sapiens (Human))
Frederick National Laboratory For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50520121(CHEMBL4441671 | US10844044, Example 1)
Affinity DataKi:  0.0440nMAssay Description:Competitive inhibition of human N-terminal His6-SUMO tagged WDR5 (22 to 334 residues) expressed in Escherichia coli BL21-Gold(DE3) cells using 10-mer...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602062(US11643417, Ex. No. 77)
Affinity DataKi:  0.0440nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602168(US11643417, Ex. No. 163)
Affinity DataKi:  0.0440nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602080(US11643417, Ex. No. 95)
Affinity DataKi:  0.0440nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602040(US11643417, Ex. No. 57)
Affinity DataKi:  0.0450nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602039(US11643417, Ex. No. 56 | US11643417, Ex. No. 68 | ...)
Affinity DataKi:  0.0460nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602045(US11643417, Ex. No. 62)
Affinity DataKi:  0.0460nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602114(US11643417, Ex. No. 127 | US11643417, Ex. No. 128)
Affinity DataKi:  0.0530nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602088(US11643417, Ex. No. 103)
Affinity DataKi:  0.0580nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM601998(US11643417, Ex. No. 30)
Affinity DataKi:  0.0580nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602112(US11643417, Ex. No. 125 | US11643417, Ex. No. 126)
Affinity DataKi:  0.0590nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM601978(US11643417, Ex. No. 11 | US11643417, Ex. No. 12 | ...)
Affinity DataKi:  0.0600nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602029(US11643417, Ex. No. 46)
Affinity DataKi:  0.0710nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602039(US11643417, Ex. No. 56 | US11643417, Ex. No. 68 | ...)
Affinity DataKi:  0.0720nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602039(US11643417, Ex. No. 56 | US11643417, Ex. No. 68 | ...)
Affinity DataKi:  0.0730nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602178(US11643417, Ex. No. 2-06)
Affinity DataKi:  0.0740nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602084(US11643417, Ex. No. 110 | US11643417, Ex. No. 99)
Affinity DataKi:  0.0760nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602001(US11643417, Ex. No. 33)
Affinity DataKi:  0.0790nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602093(US11643417, Ex. No. 107)
Affinity DataKi:  0.0860nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602000(US11643417, Ex. No. 32)
Affinity DataKi:  0.0920nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602035(US11643417, Ex. No. 52 | US11643417, Ex. No. 53)
Affinity DataKi:  0.0920nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602167(US11643417, Ex. No. 162)
Affinity DataKi:  0.0920nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602152(US11643417, Ex. No. 152)
Affinity DataKi:  0.0930nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM602165(US11643417, Ex. No. 160)
Affinity DataKi:  0.0980nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM601987(US11643417, Ex. No. 19)
Affinity DataKi:  0.101nMAssay Description:The calculation of the Pim-1 inhibitory activity of the compound was performed using the following solution according to the protocol attached to ADP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 3495 total ) | Next | Last >>
Jump to: